Cervix BT - 2016

First page Previous page 990 Next page Last page

morbidity 3y ≥G3: 10% 3% IGABT/ChTh: 79% NOCECA: 63% LC 3 y: 90% OS 3 y:

Lindegaard et al. Acta Oncologica 2013

Made with